Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Retraction: Oncogene PKCĪµ controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.

Niture SK, Gnatt A, Jaiswal AK.

J Cell Sci. 2017 Feb 15;130(4):815. doi: 10.1242/jcs.201954. No abstract available.

2.

Mechanism of RNA polymerase II bypass of oxidative cyclopurine DNA lesions.

Walmacq C, Wang L, Chong J, Scibelli K, Lubkowska L, Gnatt A, Brooks PJ, Wang D, Kashlev M.

Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E410-9. doi: 10.1073/pnas.1415186112. Epub 2015 Jan 20.

3.

Oncogene PKCĪµ controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.

Niture SK, Gnatt A, Jaiswal AK.

J Cell Sci. 2013 Dec 15;126(Pt 24):5657-69. doi: 10.1242/jcs.133819. Epub 2013 Oct 14. Retraction in: J Cell Sci. 2017 Feb 15;130(4):815.

4.

A quantitative assay to study protein:DNA interactions, discover transcriptional regulators of gene expression, and identify novel anti-tumor agents.

Underwood KF, Mochin MT, Brusgard JL, Choe M, Gnatt A, Passaniti A.

J Vis Exp. 2013 Aug 31;(78). doi: 10.3791/50512.

5.

Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.

Arnold JJ, Sharma SD, Feng JY, Ray AS, Smidansky ED, Kireeva ML, Cho A, Perry J, Vela JE, Park Y, Xu Y, Tian Y, Babusis D, Barauskus O, Peterson BR, Gnatt A, Kashlev M, Zhong W, Cameron CE.

PLoS Pathog. 2012;8(11):e1003030. doi: 10.1371/journal.ppat.1003030. Epub 2012 Nov 15.

6.

Regulation of mammalian transcription by Gdown1 through a novel steric crosstalk revealed by cryo-EM.

Wu YM, Chang JW, Wang CH, Lin YC, Wu PL, Huang SH, Chang CC, Hu X, Gnatt A, Chang WH.

EMBO J. 2012 Aug 29;31(17):3575-87. doi: 10.1038/emboj.2012.205. Epub 2012 Jul 31.

7.

Efficient reconstitution of transcription elongation complexes for single-molecule studies of eukaryotic RNA polymerase II.

Palangat M, Larson MH, Hu X, Gnatt A, Block SM, Landick R.

Transcription. 2012 May-Jun;3(3):146-53. doi: 10.4161/trns.20269.

8.

Transcriptional regulation by Pol II(G) involving mediator and competitive interactions of Gdown1 and TFIIF with Pol II.

Jishage M, Malik S, Wagner U, Uberheide B, Ishihama Y, Hu X, Chait BT, Gnatt A, Ren B, Roeder RG.

Mol Cell. 2012 Jan 13;45(1):51-63. doi: 10.1016/j.molcel.2011.12.014. Erratum in: Mol Cell. 2012 Aug 10;47(3):491-2.

9.

Functional association of Gdown1 with RNA polymerase II poised on human genes.

Cheng B, Li T, Rahl PB, Adamson TE, Loudas NB, Guo J, Varzavand K, Cooper JJ, Hu X, Gnatt A, Young RA, Price DH.

Mol Cell. 2012 Jan 13;45(1):38-50. doi: 10.1016/j.molcel.2011.10.022.

10.

Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity.

Underwood KF, D'Souza DR, Mochin-Peters M, Pierce AD, Kommineni S, Choe M, Bennett J, Gnatt A, Habtemariam B, MacKerell AD Jr, Passaniti A.

J Bone Miner Res. 2012 Apr;27(4):913-25. doi: 10.1002/jbmr.1504.

11.

Differential blocking effects of the acetaldehyde-derived DNA lesion N2-ethyl-2'-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases.

Cheng TF, Hu X, Gnatt A, Brooks PJ.

J Biol Chem. 2008 Oct 10;283(41):27820-8. doi: 10.1074/jbc.M804086200. Epub 2008 Jul 31.

12.

Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.

Hubbard K, Catalano J, Puri RK, Gnatt A.

BMC Cancer. 2008 May 12;8:133. doi: 10.1186/1471-2407-8-133.

13.

A Mediator-responsive form of metazoan RNA polymerase II.

Hu X, Malik S, Negroiu CC, Hubbard K, Velalar CN, Hampton B, Grosu D, Catalano J, Roeder RG, Gnatt A.

Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9506-11. Epub 2006 Jun 12.

14.

Fcp1 directly recognizes the C-terminal domain (CTD) and interacts with a site on RNA polymerase II distinct from the CTD.

Suh MH, Ye P, Zhang M, Hausmann S, Shuman S, Gnatt AL, Fu J.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17314-9. Epub 2005 Nov 21.

15.

Elongation by RNA polymerase II: structure-function relationship.

Gnatt A.

Biochim Biophys Acta. 2002 Sep 13;1577(2):175-90. Review.

PMID:
12213651
16.

Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 A resolution.

Gnatt AL, Cramer P, Fu J, Bushnell DA, Kornberg RD.

Science. 2001 Jun 8;292(5523):1876-82. Epub 2001 Apr 19.

17.

Architecture of RNA polymerase II and implications for the transcription mechanism.

Cramer P, Bushnell DA, Fu J, Gnatt AL, Maier-Davis B, Thompson NE, Burgess RR, Edwards AM, David PR, Kornberg RD.

Science. 2000 Apr 28;288(5466):640-9.

18.

Yeast RNA polymerase II at 5 A resolution.

Fu J, Gnatt AL, Bushnell DA, Jensen GJ, Thompson NE, Burgess RR, David PR, Kornberg RD.

Cell. 1999 Sep 17;98(6):799-810.

19.

Electron crystal structure of an RNA polymerase II transcription elongation complex.

Poglitsch CL, Meredith GD, Gnatt AL, Jensen GJ, Chang WH, Fu J, Kornberg RD.

Cell. 1999 Sep 17;98(6):791-8.

20.

Repeated tertiary fold of RNA polymerase II and implications for DNA binding.

Fu J, Gerstein M, David PR, Gnatt AL, Bushnell DA, Edwards AM, Kornberg RD.

J Mol Biol. 1998 Jul 17;280(3):317-22.

PMID:
9665838
21.

Formation and crystallization of yeast RNA polymerase II elongation complexes.

Gnatt A, Fu J, Kornberg RD.

J Biol Chem. 1997 Dec 5;272(49):30799-805.

22.

Evidence for a mediator cycle at the initiation of transcription.

Svejstrup JQ, Li Y, Fellows J, Gnatt A, Bjorklund S, Kornberg RD.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6075-8.

23.
24.

Testicular amplification and impaired transmission of human butyrylcholinesterase cDNA in transgenic mice.

Beeri R, Gnatt A, Lapidot-Lifson Y, Ginzberg D, Shani M, Soreq H, Zakut H.

Hum Reprod. 1994 Feb;9(2):284-92.

PMID:
8027285
25.
26.

Structure-function relationship studies in human cholinesterases reveal genomic origins for individual variations in cholinergic drug responses.

Loewenstein Y, Gnatt A, Neville LF, Zakut H, Soreq H.

Prog Neuropsychopharmacol Biol Psychiatry. 1993 Nov;17(6):905-26. Review.

PMID:
8278601
27.

Excavations into the active-site gorge of cholinesterases.

Soreq H, Gnatt A, Loewenstein Y, Neville LF.

Trends Biochem Sci. 1992 Sep;17(9):353-8. Review.

PMID:
1412713
28.

Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.

Neville LF, Gnatt A, Loewenstein Y, Seidman S, Ehrlich G, Soreq H.

EMBO J. 1992 Apr;11(4):1641-9.

29.

Human acetylcholinesterase and butyrylcholinesterase are encoded by two distinct genes.

Gnatt A, Ginzberg D, Lieman-Hurwitz J, Zamir R, Zakut H, Soreq H.

Cell Mol Neurobiol. 1991 Feb;11(1):91-104.

PMID:
2013062
30.

Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.

Neville LF, Gnatt A, Padan R, Seidman S, Soreq H.

J Biol Chem. 1990 Dec 5;265(34):20735-8.

31.

Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.

Soreq H, Ben-Aziz R, Prody CA, Seidman S, Gnatt A, Neville L, Lieman-Hurwitz J, Lev-Lehman E, Ginzberg D, Lipidot-Lifson Y, et al.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9688-92.

32.
33.
34.

Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues.

Prody CA, Zevin-Sonkin D, Gnatt A, Goldberg O, Soreq H.

Proc Natl Acad Sci U S A. 1987 Jun;84(11):3555-9.

35.

Molecular biological search for human genes encoding cholinesterases.

Soreq H, Gnatt A.

Mol Neurobiol. 1987 Spring-Summer;1(1-2):47-80. Review.

PMID:
3077058
36.

Molecular cloning of human cholinesterase genes: potential applications in neurotoxicology.

Gnatt A, Soreq H.

Prog Clin Biol Res. 1987;253:111-9. No abstract available.

PMID:
2963345
37.

Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone.

Prody C, Zevin-Sonkin D, Gnatt A, Koch R, Zisling R, Goldberg O, Soreq H.

J Neurosci Res. 1986;16(1):25-35.

PMID:
3755763

Supplemental Content

Support Center